TopSpin nabs first commercial install for intravascular MRI

TriMed Staff | | Health Imaging | Practice Management
Topspin Medical in Lod, Israel, has installed its Cathamaran Intravascular MRI System at ZOL Hospital in Genk, Belgium.

ZOL Hospital said the system will be used in a post-market study of coronary plaque lipid characterization by IVMRI performed during diagnostic or interventional catheterization [MIRACLE study], which is designed to collect data on a widespread post-market clinical experience to evaluate how lipid quantification with the IVMRI System may be used to guide patient treatment.

TopSpin said it expects to install additional Cathamaran Intravascular MRI Systems in the Benelux territory in the course of the current quarter.

TriMed Staff

Related Content

Clinicians want AI to show its work
Multidose contrast injectors could increase waste in some radiology departments
Imaging leaders share 7 key considerations for remote scanning programs
Policies and regulations shaping radiology in 2025
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.